Volume: 57 Issue: 1
Year: 2026, Page: 1-13, Doi: https://doi.org/10.51966/jvas.2026.57.1.1-13
Received: Jan. 2, 2026 Accepted: Jan. 26, 2026 Published: March 31, 2026
Bovine mastitis remains a significant constraint to dairy production worldwide, resulting in substantial economic losses, animal welfare concerns and growing limitations of antimicrobial-based therapies due to antimicrobial resistance and regulatory restrictions. Mesenchymal stem cell (MSC) therapy demonstrates consistent immunomodulatory, antimicrobial and regenerative effects that directly address the complex pathophysiology of bovine mastitis. Across experimental and early clinical studies, MSC administration results in a marked reduction in mammary inflammation, reflected by decreased somatic cell counts, attenuated leukocyte infiltration and suppression of pro-inflammatory cytokines. While bacteriological cure rates vary depending on the pathogen type and disease severity, MSC therapy consistently improves inflammatory resolution and clinical recovery, particularly in cases of acute mastitis. MSC-derived paracrine factors and extracellular vesicles support epithelial regeneration, angiogenesis and extracellular matrix remodelling, leading to faster restoration of milk yield, improved milk composition and reduced risk of fibrosis. Clinical studies have reported that both autologous and allogeneic MSCs are well-tolerated in dairy cattle, with no significant local or systemic adverse effects and minimal immunogenicity. Therefore, MSC-based treatments have the potential to reduce reliance on antibiotics and eliminate milk withdrawal periods, offering clear economic and public health benefits. However, therapeutic efficacy is influenced by cell source, route of administration, dosing strategy and mastitis phenotype, underscoring the need for optimized and standardized approaches. Collectively, the available evidence demonstrates that MSC therapy delivers reproducible anti-inflammatory and regenerative benefits in bovine mastitis, representing a viable antimicrobial-sparing strategy, particularly when integrated with conventional treatments in chronic or recurrent cases.
Keywords: Mesenchymal stem cells, regenerative medicine, stem cell therapy, inflammation
Abreu, S. C., Weiss, D. J., & Rocco, P. R. M. (2016). Extracellular vesicles derived from mesenchymal stromal cells: A therapeutic option in respiratory diseases? Stem Cell Research & Therapy, 7(1), 53. https://doi.org/10.1186/s13287-016-0317-0
Alcayaga-Miranda, F., Cuenca, J., & Khoury, M. (2017). Antimicrobial Activity of Mesenchymal Stem Cells: Current Status and New Perspectives of Antimicrobial Peptide-Based Therapies. Frontiers in Immunology, 8, 339. https://doi.org/10.3389/fimmu.2017.00339
Ali, L., Shaaban, F., Sokhn, E. S., & Saleh, F. A. (2025). A systematic review of preclinical studies on therapeutic potential of mesenchymal stem/stromal cells and their secretome in bacterial infections. Stem Cell Research & Therapy, 16(1), 456. https://doi.org/10.1186/s13287-025-04570-5
Alvites, R., Branquinho, M., Sousa, A. C., Lopes, B., Sousa, P., & Maurício, A. C. (2022). Mesenchymal Stem/Stromal Cells and Their Paracrine Activity-Immunomodulation Mechanisms and How to Influence the Therapeutic Potential. Pharmaceutics, 14(2), 381. https://doi.org/10.3390/pharmaceutics14020381
Bagno, L. L., Salerno, A. G., Balkan, W., & Hare, J. M. (2022). Mechanism of Action of Mesenchymal Stem Cells (MSCs): Impact of delivery method. Expert Opinion on Biological Therapy, 22(4), 449–463. https://doi.org/10.1080/14712598.2022.2016695
Banu, S. A., Mamachan, M., El-Husseiny, H. M., Golchin, A., & Sharun, K. (2025). Mesenchymal stem cell therapy in veterinary orthopaedics: Evidence from canine clinical medicine. Veterinary Research Communications, 49(5), 290. https://doi.org/10.1007/s11259-025-10843-4
Boireau, C., Cazeau, G., Jarrige, N., Calavas, D., Madec, J.-Y., Leblond, A., Haenni, M., & Gay, É. (2018). Antimicrobial resistance in bacteria isolated from mastitis in dairy cattle in France, 2006–2016. Journal of Dairy Science, 101(10), 9451–9462. https://doi.org/10.3168/jds.2018-14835
Bosnakovski, D., Mizuno, M., Kim, G., Takagi, S., Okumura, M., & Fujinaga, T. (2005). Isolation and multilineage differentiation of bovine bone marrow mesenchymal stem cells. Cell and Tissue Research, 319(2), 243–253. https://doi.org/10.1007/s00441-004-1012-5
Cahuascanco, B., Bahamonde, J., Huaman, O., Jervis, M., Cortez, J., Palomino, J., Escobar, A., Retamal, P., Torres, C. G., & Peralta, O. A. (2019). Bovine fetal mesenchymal stem cells exert antiproliferative effect against mastitis causing pathogen Staphylococcus aureus. Veterinary Research, 50(1), 25. https://doi.org/10.1186/s13567-019-0643-1
Cobirka, M., Tancin, V., & Slama, P. (2020). Epidemiology and Classification of Mastitis. Animals : An Open Access Journal from MDPI, 10(12), 2212. https://doi.org/10.3390/ani10122212
Colbath, A. C., Dow, S. W., Hopkins, L. S., Phillips, J. N., McIlwraith, C. W., & Goodrich, L. R. (2020). Allogeneic vs. autologous intra-articular mesenchymal stem cell injection within normal horses: Clinical and cytological comparisons suggest safety. Equine Veterinary Journal, 52(1), 144–151. https://doi.org/10.1111/evj.13136
Costa, L. V., Gebara, C., Zacaroni, O. de F., Freitas, N. E., Silva, A. N. da, Prado, C. S., Nunes, I. A., Cavicchioli, V. Q., Duarte, F. O. S., Lage, M. E., Alencar, F. R. de, Machado, B. A. S., Hodel, K. V. S., & Minafra, C. (2024). Antibiotic Residues in Raw Cow’s Milk: A Systematic Review of the Last Decade. Foods (Basel, Switzerland), 13(23), 3758. https://doi.org/10.3390/foods13233758
Denys, M., Léon, A., Robert, C., Saulnier, N., Josson-Schramme, A., Legrand, L., Wimel, L., Maddens, S., & Pronost, S. (2020). Biosafety Evaluation of Equine Umbilical Cord-Derived Mesenchymal Stromal Cells by Systematic Pathogen Screening in Peripheral Maternal Blood and Paired UC-MSCs. Biopreservation and Biobanking, 18(2), 73–81. https://doi.org/10.1089/bio.2019.0071
Deus, I. A., Mano, J. F., & Custódio, C. A. (2020). Perinatal tissues and cells in tissue engineering and regenerative medicine. Acta Biomaterialia, 110, 1–14. https://doi.org/10.1016/j.actbio.2020.04.035
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D., & Horwitz, E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315–317. https://doi.org/10.1080/14653240600855905
El-Badawy, A., Amer, M., Abdelbaset, R., Sherif, S. N., Abo-Elela, M., Ghallab, Y. H., Abdelhamid, H., Ismail, Y., & El-Badri, N. (2016). Adipose Stem Cells Display Higher Regenerative Capacities and More Adaptable Electro-Kinetic Properties Compared to Bone Marrow-Derived Mesenchymal Stromal Cells. Scientific Reports, 6, 37801. https://doi.org/10.1038/srep37801
Esener, N. (2025). Omics technologies in mastitis: Text mining and topic modelling analysis of global research trends. The Journal of Dairy Research, 1–11. https://doi.org/10.1017/S0022029925101830
Ezzat Alnakip, M., Quintela-Baluja, M., Böhme, K., Fernández-No, I., Caamaño-Antelo, S., Calo-Mata, P., & Barros-Velázquez, J. (2014). The Immunology of Mammary Gland of Dairy Ruminants between Healthy and Inflammatory Conditions. Journal of Veterinary Medicine, 2014, 659801. https://doi.org/10.1155/2014/659801
Ghai, S., Saini, S., Ansari, S., Verma, V., Chopra, S., Sharma, V., Devi, P., & Malakar, D. (2022). Allogenic umbilical cord blood-mesenchymal stem cells are more effective than antibiotics in alleviating subclinical mastitis in dairy cows. Theriogenology, 187, 141–151. https://doi.org/10.1016/j.theriogenology.2022.05.001
Hatipoglu, D., Ates, M. B., Sariboyaci, A. E., Uysal, O., Soykan, M. N., Altug, B., Cevizlidere, B. D., Ergen, F. B., Ghorbani, A., & Aladag, F. (2026). Therapeutic potential of human Wharton’s Jelly-derived mesenchymal stem cells (hWJ-MSCs) for treating clinical and subclinical mastitis in dairy cows. The Veterinary Journal, 315, 106534. https://doi.org/10.1016/j.tvjl.2025.106534
Hernandez, E., Llonch, P., & Turner, P. V. (2022). Applied Animal Ethics in Industrial Food Animal Production: Exploring the Role of the Veterinarian. Animals : An Open Access Journal from MDPI, 12(6), 678. https://doi.org/10.3390/ani12060678
Homma, K., Bazhanov, N., Hashimoto, K., Shimizu, M., Heathman, T., Hao, Q., Nawgiri, R., Muthukumarana, V., Lee, J. W., Prough, D. S., & Enkhbaatar, P. (2023). Mesenchymal stem cell-derived exosomes for treatment of sepsis. Frontiers in Immunology, 14, 1136964. https://doi.org/10.3389/fimmu.2023.1136964
Li, P., Ou, Q., Shi, S., & Shao, C. (2023). Immunomodulatory properties of mesenchymal stem cells/dental stem cells and their therapeutic applications. Cellular & Molecular Immunology, 20(6), 558–569. https://doi.org/10.1038/s41423-023-00998-y
Li, S., Wu, H., Han, D., Ma, S., Fan, W., Wang, Y., Zhang, R., Fan, M., Huang, Y., Fu, X., & Cao, F. (2018). A Novel Mechanism of Mesenchymal Stromal Cell-Mediated Protection against Sepsis: Restricting Inflammasome Activation in Macrophages by Increasing Mitophagy and Decreasing Mitochondrial ROS. Oxidative Medicine and Cellular Longevity, 2018, 3537609. https://doi.org/10.1155/2018/3537609
Lloyd, K. C. K., Khanna, C., Hendricks, W., Trent, J., & Kotlikoff, M. (2016). Precision medicine: An opportunity for a paradigm shift in veterinary medicine. Journal of the American Veterinary Medical Association, 248(1), 45–48. https://doi.org/10.2460/javma.248.1.45
Machado, C. de V., Telles, P. D. da S., & Nascimento, I. L. O. (2013). Immunological characteristics of mesenchymal stem cells. Revista Brasileira de Hematologia e Hemoterapia, 35(1), 62–67. https://doi.org/10.5581/1516-8484.20130017
Mamachan, M., Sharun, K., Banu, S. A., Muthu, S., Pawde, A. M., Abualigah, L., & Maiti, S. K. (2024). Mesenchymal stem cells for cartilage regeneration: Insights into molecular mechanism and therapeutic strategies. Tissue & Cell, 88, 102380. https://doi.org/10.1016/j.tice.2024.102380
Merlo, B., Gugole, P. M., & Iacono, E. (2022). An Update on Applications of Cattle Mesenchymal Stromal Cells. Animals: An Open Access Journal from MDPI, 12(15), 1956. https://doi.org/10.3390/ani12151956
Moradi, A., Bidarian, B., Mohammadian, F., Akbarian, F., Kalateh Rahmani, H., Tashakkori, N., & Khoramian, B. (2025). Trends in Antimicrobial Resistance of Major Mastitis-Causing Pathogens: A Nine-Year Study. Veterinary Medicine and Science, 11(4), e70417. https://doi.org/10.1002/vms3.70417
Morales-Ubaldo, A. L., Rivero-Perez, N., Valladares-Carranza, B., Velázquez-Ordoñez, V., Delgadillo-Ruiz, L., & Zaragoza-Bastida, A. (2023). Bovine mastitis, a worldwide impact disease: Prevalence, antimicrobial resistance, and viable alternative approaches. Veterinary and Animal Science, 21, 100306. https://doi.org/10.1016/j.vas.2023.100306
More, S. J., McAloon, C., Silva Boloña, P., O’Grady, L., O’Sullivan, F., McGrath, M., Buckley, W., Downing, K., Kelly, P., Ryan, E. G., & McCoy, F. (2022). Mastitis Control and Intramammary Antimicrobial Stewardship in Ireland: Challenges and Opportunities. Frontiers in Veterinary Science, 9, 748353. https://doi.org/10.3389/fvets.2022.748353
Nankemann, F., Leimbach, S., Nitz, J., Tellen, A., Wente, N., Zhang, Y., Klocke, D., Krebs, I., Müller, S., Teich, S., Wilm, J., Katthöfer, P., Kortstegge, J., & Krömker, V. (2025). Antibiotic Treatment vs. Non-Antibiotic Treatment in Bovine Clinical Mastitis During Lactation with Mild and Moderate Severity. Antibiotics (Basel, Switzerland), 14(7), 702. https://doi.org/10.3390/antibiotics14070702
Ni, Q., Han, G., & Pan, C. (2025). Single-cell transcriptomics reveals an abnormal immune microenvironment in plasma cell mastitis. Annals of Medicine, 57(1), 2446694. https://doi.org/10.1080/07853890.2024.2446694
P, M., S, H., R, M., M, G., & W S, K. (2011). Adult mesenchymal stem cells and cell surface characterization—A systematic review of the literature. The Open Orthopaedics Journal, 5(Suppl 2), 253–260. https://doi.org/10.2174/1874325001105010253
Peralta, O. A., Carrasco, C., Vieytes, C., Tamayo, M. J., Muñoz, I., Sepulveda, S., Tadich, T., Duchens, M., Melendez, P., Mella, A., & Torres, C. G. (2020). Safety and efficacy of a mesenchymal stem cell intramammary therapy in dairy cows with experimentally induced Staphylococcus aureus clinical mastitis. Scientific Reports, 10(1), 2843. https://doi.org/10.1038/s41598-020-59724-7
Pokorska, J., Sawicki, S., Gabryś, J., Kułaj, D., Bauer, E. A., Lenart-Boroń, A., Bulanda, K., Kuchta-Gładysz, M., Grzesiakowska, A., Kemilew, J., Barton, P. M., Lasek, O., & Bugno-Poniewierska, M. (2024). The use of stem cells in the treatment of mastitis in dairy cows. Scientific Reports, 14(1), 10349. https://doi.org/10.1038/s41598-024-61051-0
Prockop, D. J., & Oh, J. Y. (2012). Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation. Molecular Therapy: The Journal of the American Society of Gene Therapy, 20(1), 14–20. https://doi.org/10.1038/mt.2011.211
Richardet, M., Solari, H. G., Cabrera, V. E., Vissio, C., Agüero, D., Bartolomé, J. A., Bó, G. A., Bogni, C. I., & Larriestra, A. J. (2023). The Economic Evaluation of Mastitis Control Strategies in Holstein-Friesian Dairy Herds. Animals: An Open Access Journal from MDPI, 13(10), 1701. https://doi.org/10.3390/ani13101701
Ruegg, P. L. (2025a). Making Economically Efficient Treatment Decisions for Clinical Mastitis. The Veterinary Clinics of North America. Food Animal Practice, 41(2), 181–198. https://doi.org/10.1016/j.cvfa.2025.02.003
Ruegg, P. L. (2025b). The future of udder health: Antimicrobial stewardship and alternative therapy of bovine mastitis. JDS Communications, 6, S31–S36. https://doi.org/10.3168/jdsc.2025-0839
Sarsenova, M., Kim, Y., Raziyeva, K., Kazybay, B., Ogay, V., & Saparov, A. (2022). Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells. Frontiers in Immunology, 13, 1010399. https://doi.org/10.3389/fimmu.2022.1010399
Schouten, I., Bernys-Karolys, A., Schneider, P., Dror, T., Ofer, L., Shimoni, C., Nissim-Eliraz, E., Shpigel, N. Y., & Schlesinger, S. (2023). Mesenchymal stromal cells modulate infection and inflammation in the uterus and mammary gland. BMC Veterinary Research, 19, 64. https://doi.org/10.1186/s12917-023-03616-1
Schu, S., Nosov, M., O’Flynn, L., Shaw, G., Treacy, O., Barry, F., Murphy, M., O’Brien, T., & Ritter, T. (2012). Immunogenicity of allogeneic mesenchymal stem cells. Journal of Cellular and Molecular Medicine, 16(9), 2094–2103. https://doi.org/10.1111/j.1582-4934.2011.01509.x
Sharma, N., & Jeong, D. K. (2013). Stem cell research: A novel boulevard towards improved bovine mastitis management. International Journal of Biological Sciences, 9(8), 818–829. https://doi.org/10.7150/ijbs.6901
Sharun, K., Banu, S. A., Alifsha, B., Abualigah, L., Pawde, A. M., Dhama, K., & Pal, A. (2024). Mesenchymal stem cell therapy in veterinary ophthalmology: Clinical evidence and prospects. Veterinary Research Communications, 48(6), 3517–3531. https://doi.org/10.1007/s11259-024-10522-w
Sharun, K., Banu, S. A., Pawde, A. M., Dhama, K., & Pal, A. (2024). Minimal criteria for reporting mesenchymal stem cells in veterinary regenerative medicine. Veterinary Research Communications, 48(3), 1973–1976. https://doi.org/10.1007/s11259-024-10398-w
Sharun, K., Dhama, K., Jambagi, K., Pawde, A. M., & Amarpal, null. (2022). Cell-free Therapy for Inflammatory Diseases: Opportunities and Challenges. Recent Advances in Inflammation & Allergy Drug Discovery, 15(1), 5–8. https://doi.org/10.2174/2772270816666211220152218
Sharun, K., Dhama, K., Tiwari, R., Gugjoo, M. B., Iqbal Yatoo, M., Patel, S. K., Pathak, M., Karthik, K., Khurana, S. K., Singh, R., Puvvala, B., Amarpal, null, Singh, R., Singh, K. P., & Chaicumpa, W. (2021). Advances in therapeutic and managemental approaches of bovine mastitis: A comprehensive review. The Veterinary Quarterly, 41(1), 107–136. https://doi.org/10.1080/01652176.2021.1882713
Sharun, K., Musa, T. H., Musa, H. H., Kumar, R., Pawde, A. M., Chandra, V., Tuli, H. S., Dhama, K., Amarpal, null, & Sharma, G. T. (2022). Mapping global trends in adipose-derived mesenchymal stem cell research: A bibliometric analysis using scopus database. Annals of Medicine and Surgery (2012), 77, 103542. https://doi.org/10.1016/j.amsu.2022.103542
Shi, M., Liu, Z.-W., & Wang, F.-S. (2011). Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clinical and Experimental Immunology, 164(1), 1–8. https://doi.org/10.1111/j.1365-2249.2011.04327.x
Shokoohmand, A., Patel, N. M., Braid, L., Dominici, M., Heng, T. S. P., Ankrum, J. A., Barua, J., Caicedo, A., Creane, M., Davies, L., dos Santos, C. C., Enes, S. R., English, K., Farge, D., Fernández-García, M., Galipeau, J., Kadri, N., Khoury, M., Kilfeather, S., … Viswanathan, S. (2025). Fate and function of exogenously administered mesenchymal stromal cells: Current insights and future directions. Cytotherapy, 102007. https://doi.org/10.1016/j.jcyt.2025.102007
Singh, R., Bhaskar, V., Saini, S., Kumar, A., Thakur, A., Kumar, S., & Malakar, D. (2021). 143 Therapeutic efficacy and safety of adipose tissue-derived mesenchymal stem cells in treating mastitis and metritis in dairy cattle. Reproduction, Fertility and Development, 33(2), 179–179.
Soni, S., Mukherjee, R., De, U. K., Bharti, D., Singh, M., Paul, B. R., Sarkar, V. K., Sharun, K., Barkathullah, N., & Saminathan, M. (2024). Therapeutic Efficacy of Baicalein Green Biomolecule in Methicillin-Resistant Staphylococcus aureusMurine Mastitis Model. J Pure Appl Microbiol, 18(3), 1546–1557.
Thompson-Crispi, K., Atalla, H., Miglior, F., & Mallard, B. A. (2014). Bovine mastitis: Frontiers in immunogenetics. Frontiers in Immunology, 5, 493. https://doi.org/10.3389/fimmu.2014.00493
Ting, W.-J., Shaw, S. W., Hii, L.-Y., Lin, T.-Y., Chang, S.-C., Liu, K.-Y., Shen, P.-C., Chen, T.-J., & Peng, S.-Y. (2020). Therapeutic effects of conditioned—DPBS from amniotic stem cells on lactating cow mastitis. Taiwanese Journal of Obstetrics & Gynecology, 59(4), 520–526. https://doi.org/10.1016/j.tjog.2020.05.009
Torre, M. L., Lucarelli, E., Guidi, S., Ferrari, M., Alessandri, G., De Girolamo, L., Pessina, A., Ferrero, I., & Gruppo Italiano Staminali Mesenchimali (GISM). (2015). Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application. Stem Cells and Development, 24(6), 677–685. https://doi.org/10.1089/scd.2014.0299
Witkowska-Zimny, M., & Wrobel, E. (2011). Perinatal sources of mesenchymal stem cells: Wharton’s jelly, amnion and chorion. Cellular & Molecular Biology Letters, 16(3), 493–514. https://doi.org/10.2478/s11658-011-0019-7
Wu, Y., Sun, Y., Dong, X., Chen, J., Wang, Z., Chen, J., & Dong, G. (2020). The Synergism of PGN, LTA and LPS in Inducing Transcriptome Changes, Inflammatory Responses and a Decrease in Lactation as Well as the Associated Epigenetic Mechanisms in Bovine Mammary Epithelial Cells. Toxins, 12(6), 387. https://doi.org/10.3390/toxins12060387
Xunian, Z., & Kalluri, R. (2020). Biology and therapeutic potential of mesenchymal stem cell‐derived exosomes. Cancer Science, 111(9), 3100–3110. https://doi.org/10.1111/cas.14563
Yoon, J., Lee, S., Kim, M. J., & Kim, J.-H. (2025). Brief summary of the regulatory frameworks of regenerative medicine therapies. Frontiers in Pharmacology, 15, 1486812. https://doi.org/10.3389/fphar.2024.1486812
Zaripova, L. N., Midgley, A., Christmas, S. E., Beresford, M. W., Pain, C., Baildam, E. M., & Oldershaw, R. A. (2023). Mesenchymal Stem Cells in the Pathogenesis and Therapy of Autoimmune and Autoinflammatory Diseases. International Journal of Molecular Sciences, 24(22), 16040. https://doi.org/10.3390/ijms242216040
Zhao, X., & Lacasse, P. (2008). Mammary tissue damage during bovine mastitis: Causes and control. Journal of Animal Science, 86(13 Suppl), 57–65. https://doi.org/10.2527/jas.2007-0302
Zheng, Y. H., Deng, Y. Y., Lai, W., Zheng, S. Y., Bian, H. N., Liu, Z. A., Huang, Z. F., Sun, C. W., Li, H. H., Luo, H. M., Ma, L. H., Chen, H. X., & Xiong, B. (2018). Effect of bone marrow mesenchymal stem cells on the polarization of macrophages. Molecular Medicine Reports, 17(3), 4449–4459. https://doi.org/10.3892/mmr.2018.8457
© 2026 Sharun et al. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Sharun, K., Banu S.A., & Muthu S. (2026). Immunoregulatory Mechanisms of Mesenchymal Stem Cell Therapy in Bovine Mastitis. Journal of Veterinary and Animal Sciences 57 (1), 1-13 https://doi.org/10.51966/jvas.2026.57.1.1-13